Sino Medical Sciences Technology In Market Cap ($846.45 Million)
Market Cap & Net Worth: Sino Medical Sciences Technology In (688108)
Sino Medical Sciences Technology In market cap. Sino Medical Sciences Technology In (SHG:688108) has a market capitalization of $846.45 Million (CN¥5.78 Billion) as of November 8, 2026. Listed on the SHG stock exchange, this China-based company holds position #9313 globally and #2302 in its home market, demonstrating a 4.37% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sino Medical Sciences Technology In's stock price CN¥13.84 by its total outstanding shares 417952000 (417.95 Million). Also see 688108 cash generation efficiency for how efficiently the company converts equity into cash flow.
Sino Medical Sciences Technology In Market Cap History (2019–2026)
Sino Medical Sciences Technology In market cap history from 2019 to 2026. Data shows change from $991.07 Million to $846.45 Million (-6.47% CAGR). Check 688108 stock price for real-time trading data and today's change.
Sino Medical Sciences Technology In Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Sino Medical Sciences Technology In's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore how fast is Sino Medical Sciences Technology In growing its equity to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
2.24x
Sino Medical Sciences Technology In's market cap is 2.24 times its annual revenue
Latest Price to Earnings (P/E) Ratio
24.88x
Sino Medical Sciences Technology In's market cap is 24.88 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $991.07 Million | $435.91 Million | $90.04 Million | 2.27x | 11.01x |
| 2020 | $823.82 Million | $327.42 Million | $22.49 Million | 2.52x | 36.63x |
| 2021 | $502.12 Million | $194.36 Million | -$130.77 Million | 2.58x | N/A |
| 2022 | $349.22 Million | $192.85 Million | -$162.38 Million | 1.81x | N/A |
| 2023 | $767.55 Million | $343.26 Million | -$39.63 Million | 2.24x | N/A |
| 2024 | $596.92 Million | $458.74 Million | $1.50 Million | 1.30x | 398.53x |
| 2025 | $1.18 Billion | $525.41 Million | $47.29 Million | 2.24x | 24.88x |
Competitor Companies of 688108 by Market Capitalization
Companies near Sino Medical Sciences Technology In in the global market cap rankings as of November 8, 2026. Also see 688108 total asset value for a full breakdown of the balance sheet.
Key companies related to Sino Medical Sciences Technology In by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #109 globally with a market cap of $191.15 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #188 globally with a market cap of $124.99 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #222 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #233 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #109 | Abbott Laboratories | NYSE:ABT | $191.15 Billion | $109.93 |
| #188 | Stryker Corporation | NYSE:SYK | $124.99 Billion | $325.87 |
| #222 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $101.80 |
| #233 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Sino Medical Sciences Technology In (2019–2026)
Market capitalization of Sino Medical Sciences Technology In from 2019 to today. Between 2019 and today, Sino Medical Sciences Technology In's market cap moved from $991.07 Million to $ 846.45 Million, with a yearly change of -6.47%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥846.45 Million | -28.07% |
| 2025 | CN¥1.18 Billion | +97.13% |
| 2024 | CN¥596.92 Million | -22.23% |
| 2023 | CN¥767.55 Million | +119.79% |
| 2022 | CN¥349.22 Million | -30.45% |
| 2021 | CN¥502.12 Million | -39.05% |
| 2020 | CN¥823.82 Million | -16.88% |
| 2019 | CN¥991.07 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 8th, 2026 the market cap of Sino Medical Sciences Technology In was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $846.45 Million USD |
| MoneyControl | $846.45 Million USD |
| MarketWatch | $846.45 Million USD |
| marketcap.company | $846.45 Million USD |
| Reuters | $846.45 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Sino Medical Sciences Technology In
Sino Medical Sciences Technology Inc., a medical device company, engages in the research, development, production, and distribution of interventional medical devices in China. Its products include coronary drug stents, coronary balloons catheter, intracranial rapid exchange balloons, and intracranial drug-eluting stents, as well as transapical mitral valve replacement system. Sino Medical Science… Read more